In 2021, the FDA approved the semaglutide formulation Wegovy for weight loss, based largely on the STEP trial that demonstrated a 12.4% average loss in body weight over the course of a year [8-9]
[PMID: 40642503] PubMed record related to this compound for laboratory literature review
GLP-1s are not miracle drugs for two reasons But theres a key difference between GLP-1s and historic miracle drugs such as penicillin or the polio vaccine
HIV/AIDS, Alzheimers, Parkinsons disease, asthma, different cancers, cataracts, macular degeneration, open angle glaucoma, diabetes, and many diseases of the liver, kidneys, lungs, and digestive system